Compare Sariguna Primatirta Tbk. (CLEO) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sariguna Primatirta Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Sariguna Primatirta Tbk. trades at Rp380 (market cap 9.22T, 221.6K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp151 (market cap 576.7B, 1.32M 24h volume). The key difference: Sariguna Primatirta Tbk. is far larger — about 16× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (1.32M versus 221.6K). Which is the better fit depends on your goals.
| CLEO | LABS | |
|---|---|---|
Market Cap | 9.22T | 576.7B |
Volume | 221.6K | 1.32M |
Lot | 2.22K | 13.19K |
Turnover | 84.86M | 199.2M |
Average Price | 382.94 | 151.03 |
Value | 84.86M | 199.2M |
Indicative Equilibrium Price | 384 | 147 |
Indicative Equilibrium Volume | 104K | 311 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sariguna Primatirta Tbk.
PT Sariguna Primatirta Tbk (the Company) was established on March 10, 1988 by Notarial Deed No. 87 of Soetjipto, S.H. Tanobel is the identity of PT Sariguna Primatirta, its first operation in 17th September 2003. Produced Drinking Water in Package, processed from Mount Arjuna Spring in Pandaan. In 7 March 2004, Cleo Pure Water launched as one of Tanobel superior products in various package. Such as 250 ml cup, 330 ml bottle, 550 ml bottle, 1200 ml bottle, 6 L gallon and 19 L gallon. After that, Tanobel spread its Cleo Pure Water production to various cities in Indonesia. Now, Tanobel has factories, that had equipped with integration process. From raw material provision, cup, bottle and gallon packaging until finished product. It also has strict supervision on quality and high production standard. PT Sariguna Prima Tirta in October 2008 gets international recognition ISO 9001:2000, and in October 2008 gets ISO 22000:2005.
Read more on CLEO →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
